Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Cost Effectiveness of Teriparatide for Postmenopausal Osteoporosis: A Systematic Review
Clinical Drug Investigation
2026
Alimoradnori M.
A nationwide study on the consumption and expenditure of osteoporosis medications in Iran during the period from 2001 to 2021
Archives of Osteoporosis
December 2025
Mousavi A.
Treatment of postmenopausal osteoporosis with recombinant human parathyroid hormone and electromagnetic field
Aging Clinical and Experimental Research
December 2025
Xuan M.
Open Access
Parathyroid hormone receptor agonists in the management of osteoporosis
Nature Reviews Rheumatology
October 2025
Fuggle N.
All Open Access, Green
Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies
Applied Health Economics and Health Policy
July 2025
Abdali Z.
Open Access
Changes in BMD T-score from pre-to post-treatment with biosimilar teriparatide: A single-arm, multi-center study
Bone Reports
June 2023
Soroush M.G.
Open Access
Elevation of transaminases associated with teriparatide treatment: A case report
European Journal of Hospital Pharmacy
1 September 2022
Pappalardo F.
All Open Access, Green
A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa
Applied Health Economics and Health Policy
May 2022
Nagi M.A.
QALY league table of Iran: a practical method for better resource allocation
Cost Effectiveness and Resource Allocation
December 2021
Hashempour R.
Open Access
Markov models for economic evaluation in osteoporosis treatment
Mathematics
September-2 2021
Osca-Guadalajara M.
Open Access
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Pharmacoeconomics
February 2021
Li N.
Open Access
Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience
Expert Review of Pharmacoeconomics and Outcomes Research
2021
Fatemi B.